Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2019-12-05 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于控股股东部分股权解除质押及再质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the partial release and re-pledging of shares by the controlling shareholder of the company. It details the number of shares pledged, released, and re-pledged, the financing purpose, risk assessment, and related financial data of the controlling shareholder. There is no indication that this is a full financial report, audit report, or earnings release. The content focuses on share pledge and financing activities related to the controlling shareholder's shares. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length and detail support it being a substantive announcement rather than a brief notice or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2019-12-05 Chinese
关于控股股东部分股权解除质押及再质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the partial release and re-pledging of shares by the controlling shareholder of the company. It details the number of shares pledged, released, and re-pledged, the financing purpose, risk assessment, and related financial data of the controlling shareholder. There is no indication that this is a full financial report, earnings release, or management discussion. The content focuses on share pledge and financing activities by the controlling shareholder, which fits the category of Capital/Financing Update (CAP). The document length is about 4693 characters, which is sufficient for a detailed announcement but not a full annual or interim report. Therefore, the classification is Capital/Financing Update (CAP) with high confidence.
2019-11-27 Chinese
关于控股股东部分股权解除质押及再质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the partial release and re-pledging of shares by the controlling shareholder of the company. It details the number of shares pledged, released, and re-pledged, the financing purpose, shareholder information, and risk assessment related to share pledges. There are no financial statements or comprehensive financial reports included. The content focuses on share pledge activities and related shareholder information, which fits the category of Capital/Financing Update (CAP). The document length is about 4748 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, the appropriate classification is CAP with high confidence.
2019-11-21 Chinese
关于持股5%以上股东部分股权质押的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the pledge of shares by a shareholder holding more than 5% of the company's shares. It details the number of shares pledged, the pledgee, and the proportion of shares pledged relative to total holdings and company shares. There is no financial report, earnings data, or management discussion. The document is a regulatory disclosure about a significant shareholder's share pledge, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2019-11-15 Chinese
收到龚虹嘉先生接到中国证券监督管理委员会立案调查通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (510 characters) regarding a regulatory investigation notice received by an individual (龚虹嘉) from the China Securities Regulatory Commission. It clarifies that the investigation is personal and does not affect the company or its operations. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. This fits the description of a Regulatory Filing (RNS) as it is a compliance-related announcement about a legal/regulatory matter without substantive financial or management report content.
2019-11-13 Chinese
2019年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2019 fifth extraordinary general meeting of shareholders of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It includes details about the meeting date, attendance, voting results, and legal witness statements. The key content is the approval of the appointment of an audit firm for the 2019 fiscal year. The document is short (1537 characters) and primarily reports the voting results and meeting details rather than providing a full audit report or financial statements. It is not an annual report, audit report, or interim report itself, but an official announcement of shareholder meeting resolutions and voting outcomes. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-11-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.